Article info

A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial

Authors

  • Marios C Pantzaris The Cyprus Institute of Neurology and Genetics (CING) Neurology Clinic C and PALUPA Medical Ltd, Nicosia, Cyprus PubMed articlesGoogle scholar articles
  • George N Loukaides The Cyprus Institute of Neurology and Genetics (CING) Neurology Clinic C and PALUPA Medical Ltd, Nicosia, Cyprus PubMed articlesGoogle scholar articles
  • Evangelia E Ntzani Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine (UISM), Ioannina, Greece PubMed articlesGoogle scholar articles
  • Ioannis S Patrikios The Cyprus Institute of Neurology and Genetics (CING) Neurology Clinic C and PALUPA Medical Ltd, Nicosia, CyprusDepartment of Health and Science, European University Cyprus, Nicosia, Cyprus PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Ioannis Patrikios and Dr Marios Pantzaris; i.patrikios{at}euc.ac.cy and patrikiosioannis{at}gmail.com
View Full Text

Citation

Pantzaris MC, Loukaides GN, Ntzani EE, et al
A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial

Publication history

  • Received September 30, 2012
  • Revised March 5, 2013
  • Accepted March 7, 2013
  • First published April 17, 2013.
Online issue publication 
April 17, 2013
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.